Mobile Health Intervention to Increase Oral Cancer Therapy Adherence in Patients With Chronic Myeloid Leukemia (The REMIND System): Clinical Feasibility and Acceptability Assessment

BACKGROUND: Optimal dosing of oral tyrosine kinase inhibitor therapy is critical to treatment success and survival of patients with chronic myeloid leukemia (CML). Drug intolerance secondary to toxicities and nonadherence are significant factors in treatment failure. OBJECTIVE: The objective of this...

Descripción completa

Detalles Bibliográficos
Autores principales: Pereira-Salgado, Amanda, Westwood, Jennifer A, Russell, Lahiru, Ugalde, Anna, Ortlepp, Bronwen, Seymour, John F, Butow, Phyllis, Cavedon, Lawrence, Ong, Kevin, Aranda, Sanchia, Breen, Sibilah, Kirsa, Suzanne, Dunlevie, Andrew, Schofield, Penelope
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications 2017
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5738545/
https://www.ncbi.nlm.nih.gov/pubmed/29212628
http://dx.doi.org/10.2196/mhealth.8349

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5738545/
https://www.ncbi.nlm.nih.gov/pubmed/29212628
http://dx.doi.org/10.2196/mhealth.8349

Ejemplares similares